We believe establishing biologically faithful platforms that predict how the VEGF:VEGFR signaling system regulates vascular density and metabolism in humans through systems biology could offer a mechanistic approach to develop effective therapeutics for obesity and obesity-related metabolic disorders. The gene discussed is VEGFA; the disease is obesity due to melanocortin 4 receptor deficiency.